Armata Pharmaceuticals Inc.
ARMP | AMEX
$4.26
+$0.08 (+1.91%)
At close: Sep 21, 2026, 4:00 PM ET
$4.15
-$0.11 (-2.58%)
Pre-market:
Sep 22, 2026, 5:43 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.31 | -3.56 | -1.70 | -1.15 | -5.71 | -2.21 |
PEG Ratio | 0 | 0.05 | -0.02 | -0.09 | 0.20 | 0.05 |
PS Ratio | 46.41 | 12.93 | 25.81 | 7.72 | 29.52 | 59.53 |
PB Ratio | -1.04 | -1.39 | -3.65 | 1.18 | 5.20 | 2.60 |
P/FCF Ratio | -8.65 | -1.70 | -2.10 | -1.23 | -5.31 | -2.57 |
P/OCF Ratio | -8.83 | -1.78 | -2.46 | -1.31 | -5.60 | -2.68 |
OCF/S Ratio | -525.35 | -725.76 | -1.05K | -589.71 | -526.93 | -2.22K |
Debt / Equity Ratio | -1.32 | -2.63 | -3.75 | 1.35 | 1.50 | 0.70 |
Quick Ratio | 1.19 | 0.23 | 1.16 | 1.09 | 3.11 | 1.62 |
Current Ratio | 1.19 | 0.23 | 1.16 | 1.09 | 3.11 | 1.62 |
Asset Turnover | 0.06 | 0.06 | 0.05 | 0.05 | 0.06 | 0.02 |
Interest Coverage | -1.88 | -3.95 | -15.57 | -1.27K | -372.22 | -34.37 |
Return on Equity | 79.51% | 39.39% | 215.33% | -102.32% | -91.17% | -117.63% |
Return on Assets | -226.06% | -21.88% | -70.19% | -34.22% | -33.19% | -56.13% |
Return on Invested Capital | -43.07% | -52.02% | -44.75% | -36.94% | -35.84% | -61.53% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 68.78% | -565.37% | 78.54% | -535.75% | -347.36% | -1.66K% |
Net Profit Margin | -3.54K% | -365.60% | -1.52K% | -670.24% | -517.55% | -2.7K% |
Pretax Profit Margin | -3.54K% | -365.60% | -1.52K% | -670.24% | -517.55% | -2.7K% |
Operating Profit Margin | -636.66% | -820.18% | -902.85% | -670.77% | -532.45% | -2.62K% |
FCF Margin | -536.40% | -762.08% | -1.23K% | -629.85% | -556.08% | -2.32K% |
EBITDA Margin | -3.17K% | -132.37% | -1.45K% | -653.52% | -489.99% | -2.48K% |
Add to Watchlist
Select watchlists to add or remove ARMP